Search - tctmd.com

Displaying 601 - 620 of 1088

Sort: Relevancy | Date

EXCEL: Core Findings Revisited and New Data

Presentation TCT 2017

EXCEL Trial 3-Year Results Updated and New Data

Presenter: Antonio Colombo, David E. Kandzari, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Outcomes and Clinical Implications From DECISION-CTO

Presenter: Barry D. Rutherford, Robert W. Yeh, Seung-Whan Lee

October 31, 2017

Presentation TCT 2017

TCT 24: Subadventitial Crossing and Crushing to Recanalize In-Stent Chronic Total Occlusions: a Multicenter Registry

Presenter: Alfredo R. Galassi, Jonathan M. Hill, Lorenzo Azzalini, MD

October 31, 2017

Presentation TCT 2017

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

Presenter: Francesco Prati, Renu Virmani, Yoshinori Nagasawa, MD

October 31, 2017

Presentation TCT 2017

TCT 82: Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights from the EXCEL Trial

Presenter: David Hildick-Smith, Nicholas J. Lembo, Carlos Collet, MD

October 31, 2017

Presentation TCT 2017

TCT 80: Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation and Flutter After PCI or CABG for Left Main Disease: Analysis From the EXCEL Trial

Presenter: Davide Capodanno, Tullio Palmerini, Ioanna Kosmidou

October 31, 2017

Presentation TCT 2017

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

Presenter: Thomas F. Luscher, Fernando Alfonso

October 31, 2017

Presentation TCT 2017

Colombia Comments to Malaysia: How I Would Manage This Case

Presenter: Mohammad Al-Mutairi, Ahmed Magdy, Pablo Dario Charry Amaya

October 31, 2017

Presentation TCT 2017

Bioresorbable Scaffolds One Year After Approval: FDA Perspectives on Current and Future BRS

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Andrew Farb

October 31, 2017

Presentation TCT 2017

Malaysia Presents to Colombia: Post CABG Target Vessel Failure - Redo Bypass or PCI of Native vs Graft Vessels?

Presenter: Mohammad Al-Mutairi, Ahmed Magdy, Oteh Maskon

October 31, 2017

Presentation TCT 2017

Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

TCT 23: Rotational Atherectomy in CTO-Lesions: Too Risky?

Presenter: Alfredo R. Galassi, Jonathan M. Hill, Christina Brinkmann, MD

October 31, 2017

Presentation TCT 2017

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

Presenter: Stephan Achenbach, Jacques J. Koolen, Stefan Verheye

October 31, 2017

Presentation TCT 2017

TCT 81: Hybrid Coronary Revascularization vs Percutaneous Strategies in Unprotected Left Main Stenosis: A Propensity Match Study

Presenter: David Hildick-Smith, Nicholas J. Lembo, Alberto Alberto Repossini, MD

October 31, 2017

Presentation TCT 2017

TCT 79: What Biomarker Threshold for Periprocedural Myocardial Infarction Following PCI and CABG in Left Main Disease is Prognostically Relevant? Analysis from the EXCEL Trial

Presenter: Davide Capodanno, Tullio Palmerini, Shmuel Chen, MD

October 31, 2017

Presentation TCT 2017

Malaysia Comments to Kuwait: How I Would Manage This Case

Presenter: Mohammad Al-Mutairi, Ahmed Magdy, Amin Ariff Nuruddin

October 31, 2017

Presentation TCT 2017

Kuwait Presents to Malaysia: A Complex Coronary Case

Presenter: Mohammad Al-Mutairi, Ahmed Magdy

October 31, 2017

Presentation TCT 2017

FDA Perspectives on Short DAPT IDE Trials

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee

October 31, 2017

Presentation TCT 2017

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu

October 31, 2017

Presentation TCT 2017

TCT 22: Evaluation of the SoundBite Crossing System in a Coronary Chronic Total Occlusion (CTO) Acute Swine Model

Presenter: Alfredo R. Galassi, Jonathan M. Hill, Raja Hatem

October 31, 2017

Advertisement

EXCEL Trial 3-Year Results Updated and New Data

Outcomes and Clinical Implications From DECISION-CTO

TCT 24: Subadventitial Crossing and Crushing to Recanalize In-Stent Chronic Total Occlusions: a Multicenter Registry

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

TCT 82: Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights from the EXCEL Trial

TCT 80: Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation and Flutter After PCI or CABG for Left Main Disease: Analysis From the EXCEL Trial

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

Colombia Comments to Malaysia: How I Would Manage This Case

Bioresorbable Scaffolds One Year After Approval: FDA Perspectives on Current and Future BRS

Malaysia Presents to Colombia: Post CABG Target Vessel Failure - Redo Bypass or PCI of Native vs Graft Vessels?

Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS

TCT 23: Rotational Atherectomy in CTO-Lesions: Too Risky?

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

TCT 81: Hybrid Coronary Revascularization vs Percutaneous Strategies in Unprotected Left Main Stenosis: A Propensity Match Study

TCT 79: What Biomarker Threshold for Periprocedural Myocardial Infarction Following PCI and CABG in Left Main Disease is Prognostically Relevant? Analysis from the EXCEL Trial

Malaysia Comments to Kuwait: How I Would Manage This Case

Kuwait Presents to Malaysia: A Complex Coronary Case

FDA Perspectives on Short DAPT IDE Trials

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

TCT 22: Evaluation of the SoundBite Crossing System in a Coronary Chronic Total Occlusion (CTO) Acute Swine Model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content